Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Cure8 research brief
Why This Matters
The study suggests electroacupuncture may reduce intestinal inflammation in a rat model of ulcerative colitis by enhancing epithelial autophagy and altering the gut microbiota—mechanisms relevant to IBD pathophysiology.
These preclinical findings could point to new research directions for nonpharmacologic or microbiome-targeting therapies.
Who Should Pay Attention
Researchers (microbiome, autophagy, IBD), clinicians interested in translational IBD research, and patients curious about preclinical studies of complementary therapies.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study used a DSS-induced rat model of ulcerative colitis to test electroacupuncture (EA). The authors report that EA reduced disease activity index scores, protected colon length, lowered pro-inflammatory cytokines (TNF-α, IL-1β), and increased anti-inflammatory cytokines (IL-2, IL-10).
They assessed autophagy markers (ATG5, ATG12, LC3, p62) and PI3K/AKT/mTOR pathway activity, and performed 16S rRNA sequencing of the gut microbiota plus fecal microbiota transplantation to explore causality.
EA-treated rats showed histologic improvement, changes in autophagy-related proteins consistent with enhanced autophagy, suppression of PI3K/AKT/mTOR signaling, increased microbiota diversity, and FMT experiments that the authors interpret as linking microbiota changes to autophagy and inflammation.
The paper presents an animal (rat) experimental model and mechanistic molecular and microbiome data; it does not provide clinical evidence in humans.
If interested in nonpharmacologic or microbiota-targeting approaches, this study suggests biological pathways worth further research but does not justify clinical use of EA for people with UC without human trials.
Keep In Mind
Animal-model and mechanistic findings do not equal evidence of safety or effectiveness in people. The paper reports experiments in DSS-induced rats; human clinical trials would be required before recommending EA for UC.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan
AuthorsHuichao XU, Jianheng H, Boya C +5 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 1, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: National Natural Science Foundation of China: Study on the Regulatory Mechanism of Cellular Autophagy of Acupoint Prescription for Intestinal Diseases in Regulating Intestinal Flora Dysbiosis in Ulcerative Colitis - 82074549
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The polysaccharide from Usnea longissima ach. ameliorates DSS-induced ulcerative colitis by restoring gut microbiota homeostasis and inhibiting the NF-κB/PI3K-Akt signaling pathways.
Researchers are exploring natural compounds that may modulate gut microbes, barrier function, and immune signaling relevant to ulcerative colitis.
Cimicifuga foetida L. polysaccharide alleviates ulcerative colitis by inhibiting pyroptosis and regulating gut microbiota
Researchers are exploring plant-derived polysaccharides as potential therapies that might reduce inflammation and protect the intestinal barrier. For people with UC, therapies that reduce pyroptosis and restore...
Cod Skin Collagen Peptides Alleviate Ulcerative Colitis by Regulating Gut Microbiota to Inhibit NLRP3 Inflammasome Activation.
This preclinical study links cod skin–derived collagen peptides to reduced colitis severity in mice through changes in the gut microbiota and suppression of the NLRP3 inflammasome — pathways that could be relevant to...